{"id":"https://openalex.org/W2103590825","doi":"https://doi.org/10.1038/sj.bjp.0701315","title":"Catecholamine modulatory effects of nepicastat (RS\u201025560\u2010197), a novel, potent and selective inhibitor of dopamine\u2010\u03b2\u2010hydroxylase","display_name":"Catecholamine modulatory effects of nepicastat (RS\u201025560\u2010197), a novel, potent and selective inhibitor of dopamine\u2010\u03b2\u2010hydroxylase","alternate_titles":[],"publication_year":1997,"publication_date":"1997-08-01","ids":{"openalex":"https://openalex.org/W2103590825","doi":"https://doi.org/10.1038/sj.bjp.0701315","mag":"2103590825","pmid":"https://pubmed.ncbi.nlm.nih.gov/9283721","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1564872"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjp.0701315","doi":"https://doi.org/10.1038/sj.bjp.0701315","is_oa":false,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0701315","pdf_url":null,"source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2103590825"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1564872","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003110659","display_name":"William C. Stanley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William C. Stanley","raw_affiliation_strings":["Center for Biological Research, Roche Bioscience, Palo Alto, CA-94304, USA","Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biological Research, Roche Bioscience, Palo Alto, CA-94304, USA","institution_ids":["https://openalex.org/I129302853"]},{"raw_affiliation_string":"Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100365159","display_name":"Bin Li","orcid":"https://orcid.org/0000-0002-2387-8305","observed_orcids":["https://orcid.org/0000-0002-2387-8305"]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bin Li","raw_affiliation_strings":["Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070529034","display_name":"Douglas W. Bonhaus","orcid":"https://orcid.org/0000-0002-6567-2348","observed_orcids":["https://orcid.org/0000-0002-6567-2348"]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas W. Bonhaus","raw_affiliation_strings":["Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056694226","display_name":"Lowell G. Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lowell G. Johnson","raw_affiliation_strings":["Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063257494","display_name":"Keiho Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keiho Lee","raw_affiliation_strings":["Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112023643","display_name":"Seth Porter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Seth Porter","raw_affiliation_strings":["Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104507114","display_name":"Keith A. M. Walker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Keith Walker","raw_affiliation_strings":["Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Greg Martinez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Greg Martinez","raw_affiliation_strings":["Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111472523","display_name":"Richard M. Eglen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard M. Eglen","raw_affiliation_strings":["Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112439336","display_name":"Roger Lewis Whiting","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roger L. Whiting","raw_affiliation_strings":["Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A","institution_ids":["https://openalex.org/I129302853"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068994903","display_name":"Sharath S. Hegde","orcid":"https://orcid.org/0000-0002-8975-2756","observed_orcids":["https://orcid.org/0000-0002-8975-2756"]},"institutions":[{"id":"https://openalex.org/I129302853","display_name":"Roche (United States)","ror":"https://ror.org/011qkaj49","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sharath S. Hegde","raw_affiliation_strings":["Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biological Research, R2-101, Neurobiology Unit, Roche Bioscience, 3401 Hillview Avenue, Palo Alto, CA-94304, U.S.A","institution_ids":["https://openalex.org/I129302853"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5068994903"],"corresponding_institution_ids":["https://openalex.org/I129302853"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":0.728,"has_fulltext":false,"cited_by_count":98,"citation_normalized_percentile":{"value":0.7141075,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"121","issue":"8","first_page":"1803","last_page":"1809"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.2827000021934509,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.2827000021934509,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.1931000053882599,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.1145000010728836,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-beta-hydroxylase-inhibition","display_name":"dopamine beta-hydroxylase inhibition","score":0.8080000281333923},{"id":"https://openalex.org/keywords/catecholamines","display_name":"catecholamines","score":0.9610000252723694},{"id":"https://openalex.org/keywords/norepinephrine","display_name":"norepinephrine","score":0.9490000009536743},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.9660000205039978},{"id":"https://openalex.org/keywords/sympathetic-nerve-function","display_name":"sympathetic function","score":0.656000018119812},{"id":"https://openalex.org/keywords/congestive-heart-failure","display_name":"congestive heart failure","score":0.8930000066757202},{"id":"https://openalex.org/keywords/spontaneously-hypertensive-rats","display_name":"spontaneously hypertensive rats","score":0.9129999876022339},{"id":"https://openalex.org/keywords/enantiomers","display_name":"enantiomers","score":0.621999979019165},{"id":"https://openalex.org/keywords/r-enantiomer","display_name":"R-enantiomer","score":0.6060000061988831},{"id":"https://openalex.org/keywords/plasma-catecholamines","display_name":"plasma catecholamines","score":0.7059999704360962},{"id":"https://openalex.org/keywords/mesenteric-arteries","display_name":"mesenteric arteries","score":0.6000000238418579},{"id":"https://openalex.org/keywords/left-ventricle","display_name":"left ventricle","score":0.9800000190734863},{"id":"https://openalex.org/keywords/cerebral-cortex","display_name":"cerebral cortex","score":0.9610000252723694},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.3930000066757202}],"concepts":[{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.8416569828987122},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7183111906051636},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7150859832763672},{"id":"https://openalex.org/C2775894120","wikidata":"https://www.wikidata.org/wiki/Q271663","display_name":"Catecholamine","level":2,"score":0.6629637479782104},{"id":"https://openalex.org/C159167319","wikidata":"https://www.wikidata.org/wiki/Q420766","display_name":"Tyrosine hydroxylase","level":3,"score":0.6009169816970825},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5725064277648926},{"id":"https://openalex.org/C2776219046","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter","level":3,"score":0.4904153048992157},{"id":"https://openalex.org/C2778514916","wikidata":"https://www.wikidata.org/wiki/Q186242","display_name":"Norepinephrine","level":3,"score":0.48527809977531433},{"id":"https://openalex.org/C2778921608","wikidata":"https://www.wikidata.org/wiki/Q2002035","display_name":"Ventricle","level":2,"score":0.46679478883743286},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2173001766204834},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.19780313968658447}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002395","descriptor_name":"Catecholamines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002417","descriptor_name":"Cattle","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004299","descriptor_name":"Dopamine beta-Hydroxylase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011918","descriptor_name":"Rats, Inbred SHR","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013871","descriptor_name":"Thiones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1038/sj.bjp.0701315","doi":"https://doi.org/10.1038/sj.bjp.0701315","is_oa":false,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0701315","pdf_url":null,"source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3469733","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1564872","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:9283721","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9283721","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1564872","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1564872/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:3469733","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1564872","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W16927975","https://openalex.org/W1522881786","https://openalex.org/W1764638724","https://openalex.org/W1967340565","https://openalex.org/W1974257801","https://openalex.org/W1984193593","https://openalex.org/W1991663804","https://openalex.org/W2000307967","https://openalex.org/W2008309884","https://openalex.org/W2034649672","https://openalex.org/W2048664109","https://openalex.org/W2048741316","https://openalex.org/W2054635454","https://openalex.org/W2062126753","https://openalex.org/W2071526303","https://openalex.org/W2074051343","https://openalex.org/W2074631079","https://openalex.org/W2075699728","https://openalex.org/W2076635077","https://openalex.org/W2078256451","https://openalex.org/W2081762186","https://openalex.org/W2086235748","https://openalex.org/W2088138316","https://openalex.org/W2097727344","https://openalex.org/W2111673521","https://openalex.org/W2143540423","https://openalex.org/W2326508838","https://openalex.org/W2338638760","https://openalex.org/W2394906223","https://openalex.org/W2399296694","https://openalex.org/W2596736853","https://openalex.org/W4407023724","https://openalex.org/W4407041015"],"related_works":["https://openalex.org/W1970293967","https://openalex.org/W4385380184","https://openalex.org/W2920123851","https://openalex.org/W6890073670","https://openalex.org/W4407023724","https://openalex.org/W1976312625","https://openalex.org/W3016932470","https://openalex.org/W2086038525","https://openalex.org/W2261457708","https://openalex.org/W2082566508"],"abstract_inverted_index":{"1.":[0],"Inhibitory":[1],"modulation":[2,320],"of":[3,15,24,32,49,62,108,118,239,258,265,277,287,295,301,315,321,330,337,342,348],"sympathetic":[4,37,323,350],"nerve":[5],"function":[6],"may":[7],"have":[8],"a":[9,21,308],"favourable":[10],"impact":[11],"on":[12,291],"the":[13,26,30,54,162,173,177,197,227,231,280,322,328,340,349],"progression":[14],"congestive":[16,355],"heart":[17,356],"failure.":[18,357],"Nepicastat":[19,58,91],"is":[20,307],"novel":[22],"inhibitor":[23,314],"dopamine-beta-hydroxylase,":[25],"enzyme":[27],"which":[28,317],"catalyses":[29],"conversion":[31],"dopamine":[33,154,222,266,288],"to":[34,110,226,246],"noradrenaline":[35,150,220,259,278],"in":[36,40,44,53,149,153,158,161,179,196,212,219,230,255,262,274,284,339],"nerves.":[38],"The":[39,79,270,299],"vitro":[41],"pharmacology":[42],"and":[43,70,102,156,169,185,189,192,201,221,234,260,267,279,293,311],"vivo":[45],"catecholamine":[46],"modulatory":[47],"effects":[48],"nepicastat":[50,109,214,240,306],"were":[51,182,289],"investigated":[52],"present":[55],"study.":[56],"2.":[57],"produced":[59,146,215,252],"concentration-dependent":[60],"inhibition":[61],"bovine":[63],"(IC50":[64,72],"=":[65,73],"8.5":[66],"+/-":[67,75],"0.8":[68,76],"nM)":[69,77],"human":[71],"9.0":[74],"dopamine-beta-hydroxylase.":[78],"corresponding":[80],"R-enantiomer":[81,228],"(RS-25560-198)":[82],"was":[83],"approximately":[84],"2-3":[85],"fold":[86],"less":[87],"potent":[88],"than":[89],"nepicastat.":[90],"had":[92],"negligible":[93],"affinity":[94],"(>":[95],"10":[96],"microM)":[97],"for":[98,143,249],"twelve":[99],"other":[100],"enzymes":[101],"thirteen":[103],"neurotransmitter":[104],"receptors.":[105],"3.":[106],"Administration":[107,238],"spontaneously":[111],"hypertensive":[112],"rats":[113],"(SHRs)":[114],"(three":[115],"consecutive":[116],"doses":[117],"either":[119],"3,":[120],"10,":[121],"30":[122,208],"or":[123,131,137,165],"100":[124],"mg":[125,139,209,242],"kg-1,":[126,140,210,243],"p.o.;":[127,141],"12":[128],"h":[129],"apart)":[130],"beagle":[132,247],"dogs":[133,248],"(0.05,":[134],"0.5,":[135],"1.5":[136],"5":[138,144],"b.i.d.,":[142],"days)":[145],"dose-dependent":[147],"decreases":[148,178,254],"content,":[151,223],"increases":[152,157,261],"content":[155],"dopamine/noradrenaline":[159,268],"ratio":[160],"artery":[163,233],"(mesenteric":[164],"renal),":[166],"left":[167,199,235],"ventricle":[168,200],"cerebral":[170,202],"cortex.":[171],"At":[172],"highest":[174],"dose":[175],"studied,":[176],"tissue":[180],"noadrenaline":[181],"47%,":[183],"35%":[184],"42%":[186],"(in":[187,194],"SHRs)":[188],"88%,":[190],"91%":[191],"96%":[193],"dogs)":[195],"artery,":[198],"cortex,":[203],"respectively.":[204,297],"When":[205],"tested":[206],"at":[207],"p.o.,":[211],"SHRs,":[213],"significantly":[216],"greater":[217],"changes":[218],"as":[224,354],"compared":[225],"(RS-25560-198),":[229],"mesenteric":[232],"ventricle.":[236],"4.":[237],"(2":[241],"b.i.d,":[244],"p.o.)":[245],"15":[250],"days":[251],"significant":[253],"plasma":[256,263,275,285],"concentrations":[257,264],"ratio.":[269],"peak":[271,281],"reduction":[272],"(52%)":[273],"concentration":[276,286],"increase":[282],"(646%)":[283],"observed":[290],"day-6":[292],"day-7":[294],"dosing,":[296],"5.":[298],"findings":[300],"this":[302],"study":[303],"suggest":[304],"that":[305],"potent,":[309],"selective":[310],"orally":[312],"active":[313],"dopamine-beta-hydroxylase":[316],"produces":[318],"gradual":[319],"nervous":[324,351],"system":[325],"by":[326],"inhibiting":[327],"biosynthesis":[329],"noradrenaline.":[331],"This":[332],"drug":[333],"may,":[334],"therefore,":[335],"be":[336],"value":[338],"treatment":[341],"cardiovascular":[343],"disorders":[344],"associated":[345],"with":[346],"over-activation":[347],"system,":[352],"such":[353]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2103590825","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
